Dario A. A. Vignali,Seng-Ryong Woo,Greg M. Delgoffe
申请号：
US16438696
公开号：
US20200010552A1
申请日:
2019.06.12
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention is directed to treatment of cancer, infections and various inflammatory and autoimmune conditions by affecting regulatory T cell stability and function via a Neuropilin-1:Semaphorin axis.
